Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Recruiting

I'm Interested

Trial ID: NCT04579588

Age - 18 Years-64 Years Gender - All Accepting Healthy Volunteers - yes

Purpose

The purpose of this study is to measure immunity to the flu vaccine over time in patients who had COVID-19. Adults who have been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Official Title

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Eligibility


Inclusion Criteria:

   - Adults enrolled in study 55689 (NCT04373148) or the general population

   - Adults diagnosed with severe or moderate COVID-19 at least 2 months prior enrollment

   - Adults without COVID-19 diagnosis for controls

Exclusion Criteria:

   - Received the influenza vaccine less than 4 months ago

   - Pregnant or lactating

   - Patients with special risks attendant to venipuncture

   - Use of immunomodulatory medications

   - Immunodeficiency or autoimmune disease

View More
View Less

Intervention(s):

biological: Flu shot

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
SNP Center Inquiry
650-521-7237

©2024 Stanford Medicine